S&P 500 rockets 9% overnight not to be outdone by the Nasdaq up 11%
Mitchell Sneddon
April 10, 2025
S&P 500 and Nasdaq rebound 9% and 11% respectively. Australian
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
S&P 500 and Nasdaq rebound 9% and 11% respectively. Australian
The CSL Ltd (ASX:CSL) share price is under the spotlight
The best time to start investing is always now. Whether
Until 45, maximise your debt. After 45, maximise passive income.
Paul Clitheroe is interviewed by Owen Rask on The Australian
The CSL Ltd (ASX:CSL) share price is in focus after
Are shares just gambling? Is the share market just a
The All Ordinaries (INDEXASX XAO) fell -2.08% on Friday, followed
The Commonwealth Bank of Australia (ASX: CBA) share price might
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
